Video

New CAR T Clinical Trials Underway at Roswell Park for Solid Tumor, Non-cancerous Diseases

While the focus and promise of CAR T-cell therapies has long been on liquid tumors and hematologic malignancies, new trials under way at Roswell Park Comprehensive Cancer Center are expanding the applications of immunotherapy to include other diseases.

News

Investigators Hope for Potential Breakthrough in Dual Cellular Therapy Approach for Advanced and Metastatic Solid Tumors

Roswell Park Comprehensive Cancer Center is moving the science forward by offering clinical trials aimed at extending the benefits of those therapies to patients with all types of solid tumors.

News

Governor Hochul Celebrates Opening of New York’s First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center In Buffalo

Governor Kathy Hochul today celebrated the opening of the Roswell Park GMP Engineering and Cell Manufacturing Facility, New York's first cell and gene therapy hub, located at Roswell Park Comprehensive Cancer Center in Buffalo.

Video

Advancing GI Surgical Care: Robotic Precision, Innovative Chemotherapy, and Multidisciplinary Expertise

Discover how Roswell Park Comprehensive Cancer Center is transforming GI cancer care with cutting-edge advancements in minimally invasive robotic surgery, innovative hepatic artery pump therapy, and multidisciplinary treatment for recurrent rectal cancer.

Video

Meet the Team: Cerrene Giordano, MD

Cerrene Giordano, MD, believes the future of dermatology involves embracing what artificial intelligence can do to help treat patients with skin cancer.

News

Can NST-628 Fill the Treatment Void For Advanced Tumors with RAS or RAF Mutations?

A phase 1 clinical trial underway at Roswell Park Comprehensive Cancer Center will evaluate the potential of a “molecular glue” to treat MAPK pathway-mutated advanced solid tumors in patients who have exhausted standard treatment options.